ACADIA PHARMACEUTICALS A/S: Financial statements 2023
CVR: 19670694
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ACADIA PHARMACEUTICALS A/S (CVR 19670694) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -151,395 and a net result of DKK -151,395 compared with DKK -253,577 the year before. Equity in the 2023 report amounted to DKK -992,772.
- Gross Profit
- DKK -151,395
- Profit/Loss
- DKK -151,395
- Equity
- DKK -992,772
- Total Assets
- DKK 3,499
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -151K | -151K | -993K | 0 |
| 2022 | - | -254K | -254K | -841K | 0 |
| 2021 | - | -21K | -21K | -588K | 0 |
| 2020 | - | - | -57K | -567K | 0 |
| 2019 | - | - | -75K | -510K | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ACADIA PHARMACEUTICALS A/S has published its annual report for 2022. Gross profit came to DKK -253,519, and the net result was DKK -253,577.
About ACADIA PHARMACEUTICALS A/S
ACADIA PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1996. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RECEPTOR TECHNOLOGIES A/S and VICH 4861 A/S. The management consists of Jennifer Jane Rhodes. The board consists of Martin Choy (chair), James Kenji Kihara, Jennifer Jane Rhodes and Peter Francis Chae. The company is owned by Acadia Pharmaceuticals Inc.. The company has 6 employees (2005). In 2025, the company reported a net result of DKK -471,043 compared with DKK -99,365 the year before. Equity in the 2025 report amounted to DKK -1,563,180.